Royalty Pharma plc
RPRX
Rang în acțiuni
#895
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Preț acțiune
$60.39
Capitalizare de piață
$26.89B
Schimbare (1 zi)
-0.93%
Schimbare (1 an)
63.17%
Țară
US
Tranzacționează Royalty Pharma plc (RPRX)
Categorie
Healthcare
EPS pentru Royalty Pharma plc (RPRX)
EPS la data de June 2026 TTM: $2.41
Conform celor mai recente rapoarte financiare și prețului acțiunilor Royalty Pharma plc, EPS-ul actual al companiei (TTM) este $2.41. La sfârșitul anului 2024, compania avea un EPS de $1.92 o scădere comparativ cu EPS-ului din 2023, care a fost de $2.54.
Istoricul EPS pentru Royalty Pharma plc din 2015 până în 2026
EPS la sfârșitul fiecărui an
| An | EPS | Schimbă |
|---|---|---|
| 2026 (TTM) | $2.41 | 34.64% |
| 2025 | $1.79 | -6.61% |
| 2024 | $1.92 | -24.41% |
| 2023 | $2.54 | 2,492.43% |
| 2022 | $0.10 | -93.45% |
| 2021 | $1.49 | -42.47% |
| 2020 | $2.60 | -59.54% |
| 2019 | $6.42 | 182.80% |
| 2018 | $2.27 | 13.86% |
| 2017 | $1.99 | 113.83% |
| 2016 | $0.93 | -2.67% |
| 2015 | $0.96 | 0.00% |
EPS pentru companii similare sau concurente
| Companie | EPS | Diferență EPS | Țara |
|---|---|---|---|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| $0.52 | -78.42% |
US
|
|
| $0.02 | -99.22% |
HK
|
